FDA approves J&J's Simponi to treat ulcerative colitis
(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulce...
Read More »
Contact Coast to Coast AM at 1-800-825-5033
(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulce...
Read More »
By David Morgan WASHINGTON (Reuters) - The U.S. Senate on Wednesday confirmed Marilyn Tavenner, a former nurse and hospital company ...
Read More »By Tom Miles GENEVA (Reuters) - People are living longer than ever and "dramatic" gains in life expectancy show no sign of slowing d...
Read More »By Jessica Toonkel NEW YORK (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pha...
Read More »
By Jessica Toonkel NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, t...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers s...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Music, art and dance therapy may relieve anxiety and similar symptoms among people wi...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Children with even slightly elevated blood lead levels are less likely to be ready to rea...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Ovarian cancer rates in the U.S. began to decline faster in 2002 around the time many o...
Read More »FRANKFURT (Reuters) - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate can...
Read More »